Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8K Sell
100
-100
-50% -$11.7K 0.01% 137
2026
Q1
$24.1K Sell
200
-400
-67% -$46.2K 0.02% 129
2025
Q4
$63.2K Buy
+600
New +$56.3K 0.06% 134

Other funds holding MRK

Entelevest's MRK Position: Q2 2026 in Review

Entelevest increased its Merck (MRK) stake by 5.9% in Q2 2026, buying an estimated $17.6K and bringing the position to 2,685 shares worth $345K. The position accounts for 0.29% of the portfolio, ranked #75.

Entelevest first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Entelevest held 2,685 shares of Merck worth $345K as of Q2 2026.
  • Entelevest bought 150 Merck shares in Q2 2026, an estimated $17.6K.
  • Merck made up 0.29% of Entelevest's portfolio in Q2 2026, its #75 holding.
  • Entelevest first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Entelevest's 13F filing for Q2 2026, filed 22 Jul 2026.